| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |